APMD
Apnimed, Inc.
Apnimed, Inc. (APMD) has 3 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 3, 2026.
Insiders have net bought $200K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Kevin R. Lind
- Employees:65
- HQ:Cambridge, MA, US
- IPO:2026-07-29
Insider Buying
$200K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
SEKHRI PAUL JFirst filing | Director | Purchase | 12,500 | $200K | Aug 3 | SEC ↗ |
Related companies
Apnimed, Inc. is in the Healthcare sector.